IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 222 filers reported holding IMMUNOGEN INC in Q3 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $194,852 | -41.0% | 12,278 | -29.9% | 0.00% | -42.9% |
| Q2 2023 | $330,433 | +325.0% | 17,511 | +11.7% | 0.01% | +250.0% |
| Q4 2022 | $77,743 | +3.7% | 15,674 | -0.0% | 0.00% | 0.0% |
| Q3 2022 | $75,000 | -12.8% | 15,676 | -17.6% | 0.00% | -33.3% |
| Q2 2022 | $86,000 | +17.8% | 19,026 | +23.8% | 0.00% | +50.0% |
| Q1 2022 | $73,000 | -36.0% | 15,374 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $114,000 | +31.0% | 15,374 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $87,000 | -20.9% | 15,374 | -8.0% | 0.00% | -20.0% |
| Q2 2021 | $110,000 | -79.4% | 16,712 | -74.7% | 0.01% | -79.2% |
| Q1 2021 | $535,000 | +302.3% | 66,040 | +219.6% | 0.02% | +500.0% |
| Q4 2020 | $133,000 | +60.2% | 20,661 | -10.7% | 0.00% | +33.3% |
| Q3 2020 | $83,000 | -94.0% | 23,126 | -92.4% | 0.00% | -92.9% |
| Q2 2020 | $1,393,000 | +295.7% | 302,829 | +193.3% | 0.04% | +320.0% |
| Q1 2020 | $352,000 | -15.2% | 103,246 | +26.9% | 0.01% | +25.0% |
| Q4 2019 | $415,000 | -77.8% | 81,364 | -66.6% | 0.01% | -70.4% |
| Q3 2017 | $1,866,000 | – | 243,949 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QVT Financial LP | 1,375,900 | $6,329,000 | 1.08% |
| Redmile Group, LLC | 12,006,979 | $55,232,000 | 1.02% |
| Birchview Capital, LP | 190,000 | $874,000 | 0.53% |
| Fernwood Investment Management, LLC | 179,340 | $825,000 | 0.41% |
| HealthCor Management, L.P. | 1,200,000 | $5,520,000 | 0.23% |
| Grace Capital | 49,500 | $228,000 | 0.20% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $479,000 | 0.19% |
| Virtus ETF Advisers LLC | 79,795 | $367,000 | 0.17% |
| PINNACLE ASSOCIATES LTD | 1,087,034 | $5,000,000 | 0.12% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 100,000 | $460,000 | 0.12% |